Abstract
Amphitrophic proteins are soluble, globular proteins that may - under certain conditions - interact reversibly with a plasma membrane. How this apparent duality in the properties of a protein is achieved has been a relatively littlestudied subject until recently. In this review we aim to summarize the current knowledge regarding some important amphitrophic systems in which the interaction with the membrane does not require post-translational functional groups, but is an intrinsic property of the protein. We discuss mechanisms and driving forces involved in membrane binding in the context of two related concepts in protein folding and function that appear to have implications for understanding the association of proteins with membranes; first, the existence of some proteins with low-energy barrier heights for protein folding. Low folding barriers and the ability of proteins to form stable molten globule states are rationales that can explain how a protein can gain access to an ensemble (or continuum) of non-native conformations that are competent membrane binders. Second, the focus on order-disorder and disorder-order transitions to explain protein function, a concept which has been mainly developed within the novel protein trinity paradigm. Here, protein function can arise from any of three thermodynamic states: a solid, crystal-like state; a dense fluid state; and an extended disordered state. Together these concepts aid to understand amphitrophic mechanism and to unify interpretations of protein behaviour with respect to the degree of (un)unfolding of the membrane-bound proteins.
Keywords: Protein-membrane, amphitrophic proteins, the protein trinity, liposomes, bicelles, micelles, transmembrane, membrane penetration, phospholipids, amphitrophic mechanism
Current Protein & Peptide Science
Title: Linking New Paradigms in Protein Chemistry to Reversible Membrane-Protein Interactions
Volume: 10 Issue: 4
Author(s): Oyvind Halskau, Arturo Muga and Aurora Martinez
Affiliation:
Keywords: Protein-membrane, amphitrophic proteins, the protein trinity, liposomes, bicelles, micelles, transmembrane, membrane penetration, phospholipids, amphitrophic mechanism
Abstract: Amphitrophic proteins are soluble, globular proteins that may - under certain conditions - interact reversibly with a plasma membrane. How this apparent duality in the properties of a protein is achieved has been a relatively littlestudied subject until recently. In this review we aim to summarize the current knowledge regarding some important amphitrophic systems in which the interaction with the membrane does not require post-translational functional groups, but is an intrinsic property of the protein. We discuss mechanisms and driving forces involved in membrane binding in the context of two related concepts in protein folding and function that appear to have implications for understanding the association of proteins with membranes; first, the existence of some proteins with low-energy barrier heights for protein folding. Low folding barriers and the ability of proteins to form stable molten globule states are rationales that can explain how a protein can gain access to an ensemble (or continuum) of non-native conformations that are competent membrane binders. Second, the focus on order-disorder and disorder-order transitions to explain protein function, a concept which has been mainly developed within the novel protein trinity paradigm. Here, protein function can arise from any of three thermodynamic states: a solid, crystal-like state; a dense fluid state; and an extended disordered state. Together these concepts aid to understand amphitrophic mechanism and to unify interpretations of protein behaviour with respect to the degree of (un)unfolding of the membrane-bound proteins.
Export Options
About this article
Cite this article as:
Halskau Oyvind, Muga Arturo and Martinez Aurora, Linking New Paradigms in Protein Chemistry to Reversible Membrane-Protein Interactions, Current Protein & Peptide Science 2009; 10 (4) . https://dx.doi.org/10.2174/138920309788922199
DOI https://dx.doi.org/10.2174/138920309788922199 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence
Current Pharmaceutical Design Human 5-HT4 and 5-HT7 Receptor Splice Variants: Are they Important?
Current Neuropharmacology RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic Outcomes
Current Gene Therapy Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor
Current Drug Targets Targeting Cancer Cells by an Oxidant-Based Therapy
Current Molecular Pharmacology Application of Bacterial Nanocellulose in Cancer Drug Delivery: A Review
Current Pharmaceutical Design Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry Bacterial Toxins: Potential Weapons Against HIV Infection
Current Pharmaceutical Design Heparanase as a Target in Cancer Therapy
Current Cancer Drug Targets The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents
Current Medicinal Chemistry How is Gene Transfection Able to Improve Current Chemotherapy? The Role of Combined Therapy in Cancer Treatment
Current Medicinal Chemistry Purinergic Receptors and Pain
Current Pharmaceutical Design Astrocytes as a 5-HT2B-Mediated SERT-Independent SSRI Target, Slowly Altering Depression-Associated Genes and Function
Current Signal Transduction Therapy Function of miRNA in Controlling Drug Resistance of Human Cancers
Current Drug Targets Exploring the Synthesis and Anticancer Potential of L-Tyrosine-Platinum(II) Hybrid Molecules
Medicinal Chemistry Caveolae and Caveolin-1: Novel Potential Targets for the Treatment of Cardiovascular Disease
Current Pharmaceutical Design Immunology Behind Tumors: A Mini Review
Current Cancer Therapy Reviews PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy Lectin-Carbohydrate Interactions: Implications for the Development of New Anticancer Agents
Current Medicinal Chemistry